Results 11 to 20 of about 83,279 (184)

RNA virus interference via CRISPR/Cas13a system in plants [PDF]

open access: yesGenome Biology, 2018
Background CRISPR/Cas systems confer immunity against invading nucleic acids and phages in bacteria and archaea. CRISPR/Cas13a (known previously as C2c2) is a class 2 type VI-A ribonuclease capable of targeting and cleaving single-stranded RNA (ssRNA ...
Rashid Aman   +7 more
doaj   +12 more sources

Advances in application of CRISPR-Cas13a system [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) and CRISPR-associated (Cas) proteins serve as an adaptive immune system that safeguards prokaryotes and some of the viruses that infect prokaryotes from foreign nucleic acids (such as ...
Yue Zhang   +7 more
doaj   +4 more sources

The CRISPR-Cas13a Gemini System for noncontiguous target RNA activation

open access: yesNature Communications
Simultaneous multi-target detection and multi-site gene editing are two key factors restricting the development of disease diagnostic and treatment technologies.
Hongrui Zhao   +9 more
doaj   +4 more sources

Bacteriophage genome engineering with CRISPR–Cas13a [PDF]

open access: yesNature Microbiology, 2022
Jumbo phages such as Pseudomonas aeruginosa ФKZ have potential as antimicrobials and as a model for uncovering basic phage biology. Both pursuits are currently limited by a lack of genetic engineering tools due to a proteinaceous 'phage nucleus' structure that protects from DNA-targeting CRISPR-Cas tools. To provide reverse-genetics tools for DNA jumbo
Jingwen Guan   +5 more
openaire   +5 more sources

Nucleic acid detection with CRISPR-Cas13a/C2c2 [PDF]

open access: yesScience, 2017
Sensitive and specific CRISPR diagnostics Methods are needed that can easily detect nucleic acids that signal the presence of pathogens, even at very low levels. Gootenberg et al. combined the allele-specific sensing ability of CRISPR-Cas13a with recombinase polymerase ...
Jonathan S. Gootenberg   +18 more
core   +7 more sources

CRISPR-Cas13a Inhibits HIV-1 Infection [PDF]

open access: yesMolecular Therapy: Nucleic Acids, 2020
CRISPR-Cas provides bacteria and archaea with immunity against invading phages and foreign plasmid DNA and has been successfully adapted for gene editing in a variety of species.
Lijuan Yin   +14 more
doaj   +3 more sources

A rapid and efficient platform for antiviral crRNA screening using CRISPR-Cas13a-based nucleic acid detection [PDF]

open access: yesFrontiers in Immunology, 2023
IntroductionRapid and high-throughput screening of antiviral clustered regularly interspaced short palindromic repeat (CRISPR) RNAs (crRNAs) is urgently required for the CRISPR-Cas13a antiviral system.
Lan Yang   +9 more
doaj   +2 more sources

Composition and Diversity of CRISPR-Cas13a Systems in the Genus Leptotrichia [PDF]

open access: yesFrontiers in Microbiology, 2019
Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas13a, previously known as CRISPR-C2c2, is the most recently identified RNA-guided RNA-targeting CRISPR-Cas system that has the unique characteristics of both targeted and collateral ...
Shinya Watanabe   +14 more
doaj   +3 more sources

Specific and sensitive detection of bovine coronavirus using CRISPR-Cas13a combined with RT-RAA technology [PDF]

open access: yesFrontiers in Veterinary Science
IntroductionBovine coronavirus (BCoV) is an important pathogen of enteric and respiratory disease in cattle, resulting in huge economic losses to the beef and dairy industries worldwide.
Zili Liang   +6 more
doaj   +2 more sources

Rapid and Fully Microfluidic Ebola Virus Detection with CRISPR-Cas13a

open access: yesACS Sensors, 2019
Highly infectious illness caused by pathogens is endemic especially in developing nations where there is limited laboratory infrastructure and trained personnel. Rapid point-of-care (POC) serological assays with minimal sample manipulation and low cost are desired in clinical practice.
Peiwu Qin   +10 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy